Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank83
3Y CAGR+10.7%
5Y CAGR+62.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.7%/yr
Annual compound
5Y CAGR
+62.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
11.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $158.19M | -8.4% |
| 2024 | $172.68M | +17.5% |
| 2023 | $147.01M | +26.1% |
| 2022 | $116.61M | +54.3% |
| 2021 | $75.59M | +437.6% |
| 2020 | $14.06M | -64.9% |
| 2019 | $40.09M | - |